Biotechnology

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Cell Therapeutics, Inc., Announces Class Action Lawsuit and Seeks to Recover Losses

LOS ANGELES--(BUSINESS WIRE)-- Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Western District of Washington on behalf of a class consisting of all persons or entities who purchased the common stock of Cell Therapeutics, Inc.

Lexicon Pharmaceuticals 2009 Annual Report to Stockholders Available Online

Lexicon Pharmaceuticals 2009 Annual Report to Stockholders Available Online PR Newswire THE WOODLANDS, Texas, March 19

Lexicon Announces Completion of Common Stock Offering

Lexicon Announces Completion of Common Stock Offering PR Newswire THE WOODLANDS, Texas, March 19

The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Cell Therapeutics, Inc.

NEW YORK, March 19, 2010 (GLOBE NEWSWIRE) -- The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Western District of Washington on behalf of purchasers of Cell Therapeutics, Inc.

DARA Receives Anticipated Notice of Non-Compliance From NASDAQ

RALEIGH, N.C., March 19, 2010 (GLOBE NEWSWIRE) -- On March 16, 2010, DARA BioSciences, Inc.

Biogen Idec to Present at the Barclays Capital 2010 Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Barclays Capital 2010 Global Healthcare Conference will be webcast live, via the internet, on Wednesday, March 24, 2010 at 8:30 a.m. EST.

Metabolix, Inc. (MBLX) Maintains Market Weight Rating

Analyst Jeff Osborne at Thomas Weisel Partners has released an update on Metabolix, Inc. (NASDAQ: MBLX).

Top Performing Industries For March 19 (CNC, HANS, CAJ, BBY, GENT)

At 1:22 p.m., Dow lost 56.38, or 0.52%, to 10,722.79, while the broader Standard & Poor's 500 index fell 6.66, or 0.57%, to 1,159.16. The Nasdaq composite index moved down 21.11, or 0.88%, to 2370.17. The industries that are driving the market today are:

Stocks That Created New 52-Week Highs (LOPE, HBOS, HDSN, ITMN, INET)

Grand Canyon Education Inc (NASDAQ: LOPE) shares climbed to $25.45, creating a new 52-week high, before slipping to $25.33, reflecting a 1.04% gain. LOPE’s quarterly earnings growth stands at 402.30% y/y. Read more about this company here.

Uptrend Spotted in Shares of Cephalon (CEPH)

SmarTrend identified an Uptrend for Cephalon (NASDAQ: CEPH) on December 29, 2009 at $61.77. In approximately 3 months, Cephalon has returned 16.7% as of today's recent price of $72.07.